Daniel Fishbein, MD (MED’85, CAS’85) and Patricia Williams, MD (MED’89, CAS’84) are the newest members of Boston University School of Medicine Dean’s Advisory Board (DAB).
The DAB, currently composed of 39 members, supports the work of the Medical School by providing Dean Karen Antman, MD, with counsel on issues affecting the school, including strategic planning, external relations, and fundraising initiatives.
Dr. Fishbein is the President of Sun Life U.S., a role he has held since 2014. He earned his Bachelor of Arts and Doctor of Medicine degrees from Boston University through the Six-Year Combined Liberal Arts and Medical Education Program. After completing his education, he decided to pursue a career in employee benefits and health plan management. Dr. Fishbein has more than 25 years of leadership experience with a track record of delivering business growth. His experience includes product development, distribution, business acquisition and integration, and building high-performance teams. He previously served as Aetna’s President, Specialty Businesses and held several other senior leadership roles during his 16-year tenure there in addition to leadership posts at New York Life and MassMutual.
Dr. Fishbein is a member of the Massachusetts Medical Society and Maine Medical Association, past chair and active board member of Spurwink Services in Portland, Maine, and serves in an advisory capacity on the board of Collective Health, an insurtech start-up based in San Francisco.
Dr. Williams most recently served as Vice President of Worldwide Safety Surveillance and Risk Management for Pfizer. She earned her Bachelor of Arts in Psychology and Doctor of Medicine degrees from Boston University. She went on to complete her residency in obstetrics and gynecology at Thomas Jefferson University Hospital in Philadelphia, where she also served as Chief Resident. Dr. Williams worked as an obstetrician-gynecologist in Pennsylvania until beginning a career in pharmaceuticals in 2001. She has nearly 20 years of leadership experience with expertise in pharmacovigilance, risk management, patient safety, Lean Six Sigma, process development, and medical education in pharmaceutical sciences. Prior to her role at Pfizer, she served as Senior Director of Women’s Health, Over-the-Counter Infant Nutritionals at Wyeth.
Dr. Williams is a Diplomat of the American Board of Obstetrics and Gynecology, a previous Trustee of Bryn Mawr Hospital, and has received multiple awards and accolades throughout her career. Now retired, she is passionate about contributing to BUSM’s antiracism and physician workforce equity initiatives.